Epigenetic Regulations in Diabetic Nephropathy

被引:73
|
作者
Lu, Zeyuan [1 ]
Liu, Na [2 ]
Wang, Feng [1 ]
机构
[1] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nephrol, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Dept Nephrol, Shanghai East Hosp, Shanghai, Peoples R China
关键词
STAGE RENAL-DISEASE; DNA METHYLATION; NONCODING RNA; MICRORNA; EXPRESSION; FIBROSIS; TARGET; FIBROGENESIS; MECHANISMS; BIOMARKERS;
D O I
10.1155/2017/7805058
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is a chronic complication of diabetes and the most common cause of end-stage kidney disease. It has been reported that multiple factors are involved in the pathogenesis of DN, while the molecular mechanisms that lead to DN are still not fully understood. Numerous risk factors for the development of diabetic nephropathy have been proposed, including ethnicity and inherited genetic differences. Recently, with the development of high-throughput technologies, there is emerging evidence that suggests the important role of epigenetic mechanisms in the pathogenesis of DN. Epigenetic regulations, including DNA methylation, noncoding RNAs, and histone modifications, play a pivotal role in DN pathogenesis by a second layer of gene regulation. All these findings can contribute to developing novel therapies for DN.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Targeting epigenetic regulations in cancer
    Ning, Bo
    Li, Wenyuan
    Zhao, Wei
    Wang, Rongfu
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (01) : 97 - 109
  • [22] Epigenetic Regulations in the Pathogenesis of Periodontitis
    Luo, Yu
    Peng, Xian
    Duan, Dingyu
    Liu, Chengcheng
    Xu, Xin
    Zhou, Xuedong
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2018, 13 (02) : 144 - 150
  • [23] Diabetic Nephropathy
    Hasslacher, C.
    Wolf, G.
    Kempe, P.
    Ritz, E.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2012, 7 : S99 - S102
  • [24] Diabetic nephropathy
    Zelmanovitz, Themis
    Gerchman, Fernando
    Balthazar, Amely P. S.
    Thomazelli, Fulvio C. S.
    Matos, Jorge D.
    Canani, Luis H.
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2009, 1
  • [25] Diabetic nephropathy
    Friedman, EA
    [J]. DIALYSIS & TRANSPLANTATION, 1996, 25 (10) : 719 - 722
  • [26] Diabetic Nephropathy
    Resl, Michael
    Clodi, Martin
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 : 67 - 77
  • [27] Diabetic nephropathy
    Groggel, GC
    [J]. ARCHIVES OF FAMILY MEDICINE, 1996, 5 (09) : 513 - 520
  • [28] Diabetic Nephropathy
    Hasslacher, C.
    Wolf, G.
    Kempe, P.
    Ritz, E.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 : S127 - S130
  • [29] Diabetic Nephropathy
    Ziegler, D.
    Bierwirth, R.
    Forst, T.
    Hilz, M.
    Jacob, S.
    Lobmann, R.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2009, 4 : S118 - S126
  • [30] Diabetic nephropathy
    Hasslacher, C.
    Kempe, P.
    Ritz, E.
    Wolf, G.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2007, 2 : S159 - S162